Consolidated Revenues of $1.84 billion, Core
EBITDAR of $247 million(1), Core Diluted EPS from
Continuing Operations of $0.25(1) and Adjusted Core
Diluted EPS from Continuing Operations of $0.35(1) in
the First Quarter
GAAP Diluted EPS from Continuing Operations
of $0.15 and EBITDAR of $233 million(1) in the First
Quarter Includes Costs of $14 million Related to Litigation,
Transaction, Integration, Research and Development, Impairment and
Other Restructuring Costs
Solid Start to Year with Core Financial
Results Above Mid-Point of Guidance
Company Reaffirms Full Year Outlook for
2016
Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND)
today announced its operating results for the first quarter ended
March 31, 2016.
Benjamin A. Breier, President and Chief Executive Officer of the
Company, commented, “We are off to a strong start in 2016 with
first quarter results at the high end of our expectations. Our
performance underscores the value of our diversified portfolio as
well as our focus on driving quality outcomes in all of our
businesses, particularly as we prepare our Hospital Division to
transition to reimbursement under long-term acute care (“LTAC”)
patient criteria later this year. The Hospital Division delivered a
solid quarter with seasonal volume increases, stable operating
results compared to the prior year and significant improvement from
the operating trends experienced in the second half of 2015. In
addition, we continued to drive growth and momentum in Kindred at
Home (“KAH”) and Kindred Hospital Rehabilitation Services (“KHRS”),
with strong sequential and year-over-year volume growth and
operating performance in these businesses. Solid execution remains
our top priority across the Company as we drive effective
patient-centered care solutions and adapt to change.”
Mr. Breier continued, “Kindred is the nation’s largest provider
of integrated care for people with post-acute and chronic care
needs. More important than our size and clinical expertise, we are
working to seamlessly connect our service lines to coordinate care
and break down traditional silos of care, in advance of the growing
demand for value-based care and payment. We are putting the key
resources in place to ensure patients receive the right care for
the right duration with targeted clinical interventions to support
shorter lengths of stay and ongoing wellness. We recently issued
our 2015 Quality, Innovation and Social Responsibility Report that
highlights our clinical expertise, capabilities across the
continuum of post-acute services and care innovations. These
strengths support smooth transitions between care settings, produce
positive clinical outcomes, and improve the patient experience. As
always, I thank Kindred’s 102,000 teammates for the exceptional
care and hope that they provide to more than one million patients
each year.”
All financial and statistical information included in this press
release reflects the continuing operations of the Company’s
businesses for all periods presented unless otherwise
indicated.
First Quarter Consolidated
Highlights(1):
- Consolidated revenues were $1.84
billion, a 9.7% year-over-year increase, and core earnings before
interest, income taxes, depreciation, amortization, rent and
certain charges (“core EBITDAR”) increased 5.4% to
$247 million compared to the same period in 2015. A
significant driver of the growth was the acquisition of Gentiva
Health Services, Inc. (“Gentiva”) on February 2, 2015.
- Core diluted earnings per share (“EPS”)
from continuing operations was $0.25 and adjusted core diluted EPS
from continuing operations was $0.35 based upon 87.2 million
weighted average diluted shares. In the same period a year ago,
core diluted EPS was $0.34 and adjusted core diluted EPS was $0.43
based upon 82.4 million weighted average diluted shares.
__________
(1) See reconciliation of core results
to generally accepted accounting principles (“GAAP”) results
beginning on page 12, including a reconciliation of core EBITDAR
and EBITDAR to the most comparable GAAP measure, income from
continuing operations, which was $25.8 million for the first
quarter of 2016.
First Quarter Consolidated Highlights(1):
(Continued)
- Core operating cash flow was
approximately breakeven(2) compared to core operating cash flows of
$38 million(2) for the same period a year ago. Core free cash flow
was a deficit of $35 million(3) compared to core free cash flows of
$6 million(3) in the same period a year ago. These quarterly
cash flow comparisons were negatively impacted by approximately
$93 million of cash flow timing differences related to the
Company’s acquisition of Gentiva in February 2015.
- GAAP consolidated operating
results:
Three months ended March 31, 2016
2015 (In thousands, except per share
amounts) Diluted earnings (loss) per common share from
continuing operations $ 0.15 $ (1.80 ) Income (loss) from
continuing operations 25,837 (134,588 ) Operating cash flows
(133,062 ) (139,602 )
- The Kindred Board of Directors declared
a cash dividend of $0.12 per share on the Company’s common stock
payable on June 10, 2016 to shareholders of record as of the close
of business on May 18, 2016.
Stephen D. Farber, Executive Vice President and Chief Financial
Officer of Kindred, noted, “Operating cash flows for the first
quarter, which are typically lower than the other quarters of the
year, were in line with our expectations and are on track for the
year. We continue to expect to generate roughly $300 million
per year in core operating cash flows(2) and approximately half of
that amount in core free cash flows(3).”
First Quarter Segment Highlights(1)(4):
Kindred’s Hospital Division first quarter revenues increased
0.4% over the prior year period to $643 million, with an increase
in same-hospital admissions of 1.2% and an increase in
same-hospital revenues per patient day of 2.0% compared to the same
period last year. As compared to the fourth quarter of 2015,
same-hospital admissions increased 9.2%. Core EBITDAR for the first
quarter increased 0.5% to $135.5 million from $134.8 million a
year ago, and increased 15.1% from $117.7 million in the fourth
quarter of 2015.
KAH first quarter revenues and core EBITDAR increased to $606
million and $91 million, respectively, as compared to the prior
year period. The home health business achieved strong growth in the
first quarter with episodic admissions increasing 2.1% and revenues
increasing 6.2% to $364 million, both over the prior year period on
a combined basis. These results were achieved despite a 10% net
reduction in home health branches since the beginning of 2015,
primarily from branch consolidations. Average home health revenue
per branch grew 14.8% during the last twelve months compared to a
year ago. The hospice business generated $176 million of
revenues in the first quarter with average daily census growth of
1.7% compared to the same period a year ago and average daily
census growth of 1.0% from the fourth quarter of 2015,
notwithstanding an 8.3% net reduction in hospice branches since the
beginning of 2015, primarily from branch consolidations. Average
hospice revenue per branch grew 8.2% during the last twelve months
compared to a year ago.
Kindred Rehabilitation Services Division revenues declined 8.4%
to $370 million and core EBITDAR declined 2.0% to $59.9 million
compared to the first quarter last year. Strong performance in the
first quarter from KHRS freestanding inpatient rehabilitation
hospitals (“IRFs”) was offset by the impact of previously reported
contract losses in RehabCare that occurred primarily in the first
half of 2015. The KHRS segment achieved strong revenue growth of
9.4% and core EBITDAR growth of 7.4% compared to the same period a
year ago, with IRF same-hospital discharges growing 5.5% during the
quarter. RehabCare revenues declined 19% to $204 million from a
year ago. Core EBITDAR and operating margins stabilized in the
first quarter with results that improved slightly from the fourth
quarter of 2015 despite the late fourth quarter cancellation of a
customer contract with 24 sites of service in connection with
litigation to collect past due amounts.
__________
(1) See reconciliation of core results to GAAP
results beginning on page 12, including a reconciliation of core
EBITDAR and EBITDAR to the most comparable GAAP measure, income
from continuing operations, which was $25.8 million for the first
quarter of 2016. (2) Core operating cash flows, similar to the GAAP
presentation, include net changes in working capital and exclude
routine capital expenditures and distributions to noncontrolling
interests. (3) Core free cash flows include net changes in working
capital, routine capital expenditures and distributions to
noncontrolling interests. (4) See same-hospital and full segment
data on pages 8 through 10.
First Quarter Segment Highlights(1):
(Continued)
Kindred’s Nursing Center Division revenues declined 0.8% to $272
million compared to the first quarter last year. Core EBITDAR was
$30 million, down from $37 million a year ago, primarily due to a
2.8% decline in average daily census, start-up losses of $1.5
million at two newly opened transitional care centers and higher
contract labor costs.
As reported segment results: Three months
ended March 31, 2016 2015 (In
thousands) Operating income: Hospital division $ 134,571 $
134,111 Kindred at Home: Home health 66,941 45,696 Hospice
24,525 16,479 91,466 62,175 Kindred Rehabilitation Services:
Kindred Hospital Rehabilitation Services 47,870 44,564 RehabCare
11,987 15,708 59,857 60,272 Nursing center division 30,100
36,963
2016 Outlook
Kindred today reaffirmed its outlook for 2016. Kindred
expects:
- Annual revenues of approximately $7.250
billion, with a range of $7.2 billion to $7.3 billion
- Core EBITDAR of approximately $990
million, with a range of $970 million to $1.010 billion
- Core diluted EPS from continuing
operations of approximately $0.90, with a range of $0.80 to
$1.00(2)
- Adjusted core diluted EPS from
continuing operations of approximately $1.25, with a range of $1.15
to $1.35(2)(3)
For the second quarter of 2016, the Company expects core EBITDAR
to approximate $260 million to $275 million, core diluted EPS from
continuing operations to approximate $0.30 to $0.40 and adjusted
core diluted EPS from continuing operations to approximate $0.40 to
$0.50.
Additionally, Kindred reaffirmed its preliminary outlook for
2017 core EBITDAR of at least $1 billion.
Mr. Breier commented, “Our focus for 2016 continues to be on
readiness for LTAC patient criteria and on driving growth and
development across our faster growing home health, hospice, and
inpatient rehabilitation businesses. We are also focused on
optimizing our LTAC hospital portfolio as a key element of our LTAC
mitigation strategy and our previously announced transactions with
Curahealth, LLC (“Curahealth”) and Select Medical Holdings
Corporation are important steps to advance these efforts.”
The Company’s outlook does not reflect the potential impact of
the previously announced definitive agreement to sell 12 LTAC
hospitals to Curahealth. The Company will make the appropriate
adjustments to its outlook once there is more clarity around the
timing of the transaction closing.
The Company’s outlook also excludes transaction costs, the
effect of any reimbursement changes, debt refinancing costs,
severance, retirement, retention, consulting and restructuring
costs, litigation and related contingency expense, integration
costs, business interruption settlements, research and development,
any further acquisitions or divestitures, any impairment charges,
any further issuances of common stock or any repurchases of common
stock.
__________
(1) See reconciliation of core results to GAAP
results beginning on page 12. (2) The EPS estimate is based upon an
estimated weighted average annual diluted share count for 2016 of
88 million shares. (3) Adjusted core diluted EPS is calculated by
excluding non-cash expenses, net of the income tax benefit, related
to amortization of intangible assets, stock-based compensation and
deferred financing costs, from core income from continuing
operations. The estimated non-cash expenses for 2016 total
approximately $53 million ($32 million net of income taxes) or
approximately $0.35 per diluted share.
All forward-looking non-GAAP financial measures contained in
this section “2016 Outlook” are provided only on a non-GAAP basis.
This is due to the inherent difficulty of forecasting the timing or
amount of items that would be included in the most directly
comparable forward-looking GAAP financial measures. As a
result, reconciliation of the forward-looking non-GAAP financial
measures to GAAP financial measures is not available without
unreasonable effort and the Company is unable to address the
probable significance of the unavailable information.
Cash Dividend
The Company announced that its Board of Directors has approved
the payment of a cash dividend of $0.12 per share of common stock
to be paid on June 10, 2016 to shareholders of record as of the
close of business on May 18, 2016.
Conference Call
As previously announced, investors and the general public may
access a live webcast of the first quarter 2016 conference call
through a link on the Company’s website at
http://investors.kindredhealthcare.com. The conference call will be
held on May 5 at 9:00 a.m. (Eastern Time).
A telephone replay of the conference call will become available
at approximately 12:00 p.m. on May 5 by dialing
(719) 457-0820, access code: 2174744. The replay will be
available through May 14.
Forward-Looking Statements and Non-GAAP
Reconciliations
See page 11 for important disclosures regarding the Company’s
forward-looking statements and the non-GAAP financial
reconciliations that follow.
About Kindred Healthcare
Kindred Healthcare, Inc., a top-90 private employer in the
United States, is a FORTUNE 500 healthcare services company based
in Louisville, Kentucky with annual revenues of approximately $7.2
billion(1). At March 31, 2016, Kindred through its subsidiaries had
approximately 102,000 employees providing healthcare services in
2,700 locations in 46 states, including 95 transitional care
hospitals, 19 inpatient rehabilitation hospitals, 92 nursing
centers, 20 sub-acute units, 618 Kindred at Home home health,
hospice and non-medical home care sites of service, 104 inpatient
rehabilitation units (hospital-based) and a contract rehabilitation
services business, RehabCare, which served 1,752 non-affiliated
sites of service. Ranked as one of Fortune magazine’s Most Admired
Healthcare Companies for seven years, Kindred’s mission is to
promote healing, provide hope, preserve dignity and produce value
for each patient, resident, family member, customer, employee and
shareholder we serve. For more information, go to
www.kindredhealthcare.com. You can also follow us on Twitter and
Facebook.
__________
(1) Revenues based upon Kindred consolidated revenues
for the twelve months ended March 31, 2016.
KINDRED HEALTHCARE, INC.
Condensed Consolidated Statement of Operations
(Unaudited) (In thousands, except per share amounts)
Three months ended March 31, 2016 2015
Revenues
$ 1,837,971 $ 1,675,967
Salaries, wages and benefits
926,214 847,093 Supplies
99,416 93,271 Rent
97,768 92,140 Other operating
expenses
214,701 197,727 General and administrative expenses
355,527 406,102 Other income
(952 ) (480 )
Litigation contingency expense
1,910 95,000 Impairment
charges
7,788 6,726 Depreciation and amortization
40,681 38,935 Interest expense
57,499 62,518
Investment income
(254 ) (741 )
1,800,298 1,838,291 Income (loss) from
continuing operations before income taxes
37,673 (162,324 )
Provision (benefit) for income taxes
11,836
(27,736 ) Income (loss) from continuing operations
25,837 (134,588 ) Discontinued operations, net of income
taxes: Loss from operations
(582 ) (3,424 ) Gain on
divestiture of operations
262 -
Loss from discontinued operations
(320 )
(3,424 ) Net income (loss)
25,517 (138,012 )
(Earnings) loss attributable to noncontrolling interests:
Continuing operations
(12,514 ) (8,847 ) Discontinued
operations
(2 ) 29
(12,516 ) (8,818 ) Income (loss) attributable
to Kindred
$ 13,001 $ (146,830 )
Amounts attributable to Kindred stockholders: Income (loss) from
continuing operations
$ 13,323 $ (143,435 ) Loss from
discontinued operations
(322 ) (3,395 )
Net income (loss)
$ 13,001 $ (146,830 )
Earnings (loss) per common share: Basic: Income (loss) from
continuing operations
$ 0.15 $ (1.80 ) Discontinued
operations: Loss from operations
- (0.04 ) Gain on
divestiture of operations
- -
Loss from discontinued operations
-
(0.04 ) Net income (loss)
$ 0.15 $ (1.84 )
Diluted: Income (loss) from continuing operations
$
0.15 $ (1.80 ) Discontinued operations: Loss from operations
- (0.04 ) Gain on divestiture of operations
-
- Loss from discontinued operations
- (0.04 ) Net income (loss)
$
0.15 $ (1.84 ) Shares used in computing
earnings (loss) per common share: Basic
86,590 79,575
Diluted
87,249 79,575 Cash dividends declared and
paid per common share
$ 0.12 $ 0.12
KINDRED HEALTHCARE, INC.
Condensed Consolidated Balance Sheet (Unaudited) (In
thousands, except per share amounts)
March 31,
December 31, 2016 2015 ASSETS Current
assets: Cash and cash equivalents
$ 105,082 $ 98,758
Insurance subsidiary investments
108,872 106,638 Accounts
receivable less allowance for loss
1,260,505 1,194,868
Inventories
28,056 27,791 Income taxes
11,283 11,790
Other
65,993 61,054
1,579,791 1,500,899 Property and equipment
2,181,989 2,162,398 Accumulated depreciation
(1,222,782 ) (1,190,402 )
959,207
971,996 Goodwill
2,683,352 2,669,810 Intangible
assets less accumulated amortization
773,237 755,655 Assets
held for sale
298 613 Insurance subsidiary investments
194,778 204,498 Deferred tax assets
100,313 104,130
Acquisition deposit
- 18,489 Other
320,328
289,133 Total assets
$ 6,611,304
$ 6,515,223
LIABILITIES AND EQUITY Current
liabilities: Accounts payable
$ 176,663 $ 187,061
Salaries, wages and other compensation
424,058 404,925 Due
to third party payors
32,785 36,251 Professional liability
risks
65,418 64,099 Other accrued liabilities
242,162
394,246 Long-term debt due within one year
25,380
24,630
966,466 1,111,212
Long-term debt
3,358,297 3,133,312 Professional liability
risks
271,974 263,273 Deferred credits and other liabilities
305,819 301,379 Equity: Stockholders' equity:
Common stock, $0.25 par value; authorized
175,000 shares; issued 85,171 shares - March 31, 2016 and 83,792
shares - December 31, 2015
21,293 20,948 Capital in excess of par value
1,728,784 1,737,747 Accumulated other comprehensive loss
(5,454 ) (2,632 ) Accumulated deficit
(243,279 ) (256,209 )
1,501,344
1,499,854 Noncontrolling interests
207,404
206,193 Total equity
1,708,748
1,706,047 Total liabilities and equity
$
6,611,304 $ 6,515,223
KINDRED HEALTHCARE,
INC. Condensed Consolidated Statement of Cash Flows
(Unaudited) (In thousands)
Three months ended
March 31, 2016 2015 Cash flows from operating
activities: Net income (loss)
$ 25,517 $ (138,012 )
Adjustments to reconcile net income (loss) to net cash used in
operating activities: Depreciation and amortization
40,783
39,077 Amortization of stock-based compensation costs
4,404
5,824 Amortization of deferred financing costs
3,567 3,062
Payment of capitalized lender fees related to debt issuance
- (28,012 ) Provision for doubtful accounts
11,725
8,292 Deferred income taxes
11,496 (25,580 ) Impairment
charges
7,788 6,726 Gain on divestiture of discontinued
operations
(262 ) - Other
303 1,997 Change in
operating assets and liabilities: Accounts receivable
(87,892 ) (31,656 ) Inventories and other assets
(5,232 ) 53,022 Accounts payable
(10,621
) 465 Income taxes
73 (5,768 ) Due to third party
payors
(4,843 ) (15,419 ) Other accrued liabilities
(129,868 ) (13,620 ) Net cash used in
operating activities
(133,062 )
(139,602 ) Cash flows from investing activities: Routine
capital expenditures
(18,106 ) (20,769 ) Development
capital expenditures
(10,019 ) (5,788 ) Acquisitions,
net of cash acquired
(26,339 ) (659,071 ) Acquisition
deposits
18,489 195,000 Sale of assets
1,081 948
Proceeds from senior unsecured notes offering held in escrow
- 1,350,000 Interest in escrow for senior unsecured notes
- 23,438 Purchase of insurance subsidiary investments
(32,841 ) (25,918 ) Sale of insurance subsidiary
investments
30,890 22,029 Net change in insurance subsidiary
cash and cash equivalents
9,958 (558 ) Net change in other
investments
(33,981 ) 24 Other
(1,919
) 5 Net cash provided by (used in) investing
activities
(62,787 ) 879,340
Cash flows from financing activities: Proceeds from
borrowings under revolving credit
533,700 807,450 Repayment
of borrowings under revolving credit
(303,100 )
(610,050 ) Proceeds from issuance of term loan, net of discount
- 199,000 Proceeds from other long-term debt
750 -
Repayment of Gentiva debt
- (1,177,363 ) Repayment of term
loan
(3,003 ) - Repayment of other long-term debt
(280 ) (441 ) Payment of deferred financing costs
(151 ) (2,538 ) Issuance of common stock in
connection with employee benefit plans
- 66 Payment of costs
associated with issuance of common stock and tangible equity units
- (915 ) Payment of dividend for mandatory redeemable
preferred stock
(2,801 ) (2,778 ) Dividends paid
(10,068 ) (9,975 ) Contributions made by
noncontrolling interests
4,368 - Distributions to
noncontrolling interests
(16,315 ) (11,019 ) Purchase
of noncontrolling interests
(1,000 ) - Other
73 1,162 Net cash provided by (used in)
financing activities
202,173 (807,401 )
Change in cash and cash equivalents
6,324 (67,663 ) Cash and
cash equivalents at beginning of period
98,758
164,188 Cash and cash equivalents at end of period
$ 105,082 $ 96,525
KINDRED HEALTHCARE, INC. Condensed Consolidated and
Business Segment Data (a) (Unaudited) (In
thousands, except per share amounts)
First First
quarter 2015 Quarters Quarter % change v.
First Second Third Fourth Year
2016 prior year Consolidated income statement
data: Revenues $ 1,675,967 $ 1,833,475 $ 1,764,516 $ 1,780,949
$ 7,054,907 $ 1,837,971 9.7 Core EBITDAR $ 234,211 $ 261,800
$ 236,477 $ 247,839 $ 980,327 $ 246,834 5.4 Rent 91,199
95,528 95,436 96,934
379,097 97,517 6.9 Core EBITDA
143,012 166,272 141,041 150,905 601,230 149,317 4.4 Depreciation
and amortization 38,935 38,625 39,329 40,362 157,251 40,681 4.5
Interest, net 44,346 56,140
56,008 55,664 212,158
57,245 29.1
Income from continuing operations before
income taxes
59,731 71,507 45,704 54,879 231,821 51,391 (14.0 ) Provision for
income taxes 22,466 25,721
15,298 13,758 77,243
16,546 (26.4 ) Income from continuing operations 37,265
45,786 30,406 41,121 154,578 34,845 (6.5 ) Noncontrolling interests
(8,847 ) (11,735 ) (9,900 ) (12,082 )
(42,564 ) (12,514 ) 41.4 Net income attributable to
Kindred $ 28,418 $ 34,051 $ 20,506 $ 29,039
$ 112,014 $ 22,331 (21.4 ) Core diluted
EPS $ 0.34 $ 0.39 $ 0.23 $ 0.33 $ 1.28 $ 0.25 (26.5 ) Adjusted core
diluted EPS $ 0.43 $ 0.51 $ 0.33 $ 0.44 $ 1.70 $ 0.35 (18.6 )
Diluted shares 82,422 86,402 86,892 87,232 86,098 87,249 5.9
Revenues by segment: Hospital division $ 640,483 $ 627,206 $
579,497 $ 593,593 $ 2,440,779 $ 643,299 0.4 Kindred at Home: Home
health 300,867 427,820 424,054 425,759 1,578,500 430,035 42.9
Hospice 119,057 178,005 181,140
178,325 656,527 176,426
48.2 419,924 605,825 605,194 604,084 2,235,027 606,461 44.4
Kindred Rehabilitation Services: Kindred Hospital Rehabilitation
Services 151,564 152,544 149,435 155,579 609,122 165,774 9.4
RehabCare 252,595 236,791
219,518 206,582 915,486
204,248 (19.1 ) 404,159 389,335 368,953 362,161 1,524,608
370,022 (8.4 ) Nursing center division 274,308
273,870 270,510 273,387
1,092,075 272,227 (0.8 ) 1,738,874 1,896,236
1,824,154 1,833,225 7,292,489 1,892,009 8.8 Eliminations
(62,907 ) (62,761 ) (59,638 ) (52,276 )
(237,582 ) (54,038 ) (14.1 ) $ 1,675,967 $ 1,833,475
$ 1,764,516 $ 1,780,949 $ 7,054,907 $
1,837,971 9.7
Core EBITDAR by segment:
Hospital division $ 134,786 $ 131,532 $ 97,128 $ 117,675 $ 481,121
$ 135,495 0.5 Kindred at Home: Home health 46,798 72,917 68,155
68,826 256,696 65,803 40.6 Hospice 16,996
27,887 34,025 30,212
109,120 24,866 46.3 63,794 100,804 102,180
99,038 365,816 90,669 42.1 Kindred Rehabilitation Services: Kindred
Hospital Rehabilitation Services 44,564 44,531 42,141 45,098
176,334 47,870 7.4 RehabCare 16,493 14,681
14,544 11,858 57,576
11,987 (27.3 ) 61,057 59,212 56,685 56,956
233,910 59,857 (2.0 ) Nursing center division 36,963 40,461 35,923
36,601 149,948 30,100 (18.6 ) Support center (62,389 )
(70,209 ) (55,439 ) (62,431 ) (250,468
) (69,287 ) 11.1 $ 234,211 $ 261,800 $ 236,477
$ 247,839 $ 980,327 $ 246,834 5.4
Core EBITDAR margin by segment: Hospital division
21.0 21.0 16.8 19.8 19.7 21.1
0.1
Kindred at Home: Home health 15.6 17.0 16.1 16.2 16.3 15.3
(0.3
) Hospice 14.3 15.7 18.8 16.9 16.6 14.1
(0.2
) Kindred at Home 15.2 16.6 16.9 16.4 16.4 15.0
(0.2
) Kindred Rehabilitation Services: Kindred Hospital Rehabilitation
Services 29.4 29.2 28.2 29.0 28.9 28.9
(0.5
) RehabCare 6.5 6.2 6.6 5.7 6.3 5.9
(0.6
) Kindred Rehabilitation Services 15.1 15.2 15.4 15.7 15.3 16.2
1.1
Nursing center division 13.5 14.8 13.3 13.4 13.7 11.1
(2.4
) Consolidated 14.0 14.3 13.4 13.9 13.9 13.4
(0.6
)
__________
(a) See reconciliation of core and
adjusted results to GAAP results beginning on page 12.
KINDRED HEALTHCARE, INC. Condensed Business
Segment Data (Continued) (Unaudited) (In thousands,
except statistics)
First First quarter
2015 Quarters Quarter % change v. First
Second Third Fourth Year 2016
prior year Hospital division: End of period data:
Number of transitional care hospitals 97 96 95 95 95 Number of
licensed beds 7,147 7,124 7,094 7,094 7,089 Revenue mix %: Medicare
56.8 55.2 57.1 57.3 56.6 57.8 Medicaid 5.5 5.3 5.3 5.1 5.3 4.2
Medicare Advantage 11.9 11.6 10.8 11.1 11.4 11.5 Medicaid Managed
4.7 5.6 6.1 6.2 5.6 5.6 Commercial insurance and other 21.1 22.3
20.7 20.3 21.1 20.9 Admissions: Medicare 8,775 8,267 7,976 8,169
33,187 8,919 1.6 Medicaid 610 610 556 520 2,296 463 (24.1 )
Medicare Advantage 1,555 1,352 1,212 1,304 5,423 1,453 (6.6 )
Medicaid Managed 643 675 646 612 2,576 733 14.0 Commercial
insurance and other 1,868 1,815 1,763
1,701 7,147 1,871 0.2 13,451 12,719
12,153 12,306 50,629 13,439 (0.1 )
Patient days: Medicare 228,483 218,577 210,870 210,409 868,339
229,004 0.2 Medicaid 28,663 25,213 23,167 21,795 98,838 21,134
(26.3 ) Medicare Advantage 48,448 44,740 39,585 41,079 173,852
45,760 (5.5 ) Medicaid Managed 22,013 24,833 24,412 24,802 96,060
25,341 15.1 Commercial insurance and other 62,241
62,922 58,631 57,321 241,115 62,769 0.8
389,848 376,285 356,665 355,406
1,478,204 384,008 (1.5 ) Average length of stay: Medicare
26.0 26.4 26.4 25.8 26.2 25.7 (1.2 ) Medicaid 47.0 41.3 41.7 41.9
43.0 45.6 (3.0 ) Medicare Advantage 31.2 33.1 32.7 31.5 32.1 31.5
1.0 Medicaid Managed 34.2 36.8 37.8 40.5 37.3 34.6 1.2 Commercial
insurance and other 33.3 34.7 33.3 33.7 33.7 33.5 0.6 Weighted
average 29.0 29.6 29.3 28.9 29.2 28.6 (1.4 ) Revenues per
admission: Medicare $ 41,483 $ 41,892 $ 41,451 $ 41,656 $ 41,620 $
41,717 0.6 Medicaid 57,594 54,795 55,415 57,724 56,352 57,928 0.6
Medicare Advantage 48,908 53,578 51,495 50,680 51,077 51,080 4.4
Medicaid Managed 46,740 51,950 54,976 60,263 53,383 49,287 5.4
Commercial insurance and other 72,395 77,110 68,151 70,735 72,150
71,651 (1.0 ) Weighted average 47,616 49,312 47,683 48,236 48,209
47,868 0.5 Revenues per patient day: Medicare $ 1,593 $ 1,584 $
1,568 $ 1,617 $ 1,591 $ 1,625 2.0 Medicaid 1,226 1,326 1,330 1,377
1,309 1,269 3.5 Medicare Advantage 1,570 1,619 1,577 1,609 1,593
1,622 3.3 Medicaid Managed 1,365 1,412 1,455 1,487 1,432 1,426 4.5
Commercial insurance and other 2,173 2,224 2,049 2,099 2,139 2,136
(1.7 ) Weighted average 1,643 1,667 1,625 1,670 1,651 1,675 1.9
Medicare case mix index (discharged
patients only)
1.166 1.163 1.150 1.164 1.162 1.163 (0.3 ) Average daily census
4,332 4,135 3,877 3,863 4,050 4,220 (2.6 ) Occupancy % 69.2 66.1
62.2 62.2 64.9 68.0 (1.7 ) Same-hospital data: Revenues (a) $
634,975 $ 622,018 $ 577,337 $ 594,091 $ 2,428,421 $ 643,413 1.3
Admissions: Medicare 8,652 8,172 7,932 8,169 32,925 8,919 3.1
Medicaid 602 608 556 520 2,286 463 (23.1 ) Medicare Advantage 1,546
1,348 1,212 1,304 5,410 1,453 (6.0 ) Medicaid Managed 640 670 644
612 2,566 733 14.5 Commercial insurance and other 1,840
1,797 1,762 1,701 7,100 1,871
1.7 13,280 12,595 12,106 12,306
50,287 13,439 1.2 Patient days: Medicare 225,992 216,230
209,662 210,466 862,350 229,004 1.3 Medicaid 28,458 25,060 23,141
21,795 98,454 21,134 (25.7 ) Medicare Advantage 48,276 44,548
39,585 41,079 173,488 45,760 (5.2 ) Medicaid Managed 21,933 24,673
24,280 24,783 95,669 25,341 15.5 Commercial insurance and other
61,715 62,462 58,625 57,325
240,127 62,769 1.7 386,374 372,973
355,293 355,448 1,470,088 384,008 (0.6 ) Total
average length of stay 29.1 29.6 29.3 28.9 29.2 28.6 (1.7 ) Total
revenues per patient day $ 1,643 $ 1,668 $ 1,625 $ 1,671 $ 1,652 $
1,676 2.0
__________
(a) See reconciliation of same-hospital
revenues to reported revenues for the Hospital Division on page
14.
KINDRED HEALTHCARE, INC. Condensed Business
Segment Data (Continued) (Unaudited) (In thousands,
except statistics)
First First quarter
2015 Quarters Quarter % change v. First
Second Third Fourth Year 2016
prior year
Kindred at Home (data combined to
include Kindred and Gentiva for each historical period):
Home Health: Sites of service (at end of period) 415 411 388 373
384 Revenue mix %: Medicare 80.9 80.4 80.0 80.0 80.3 79.8 Medicaid
2.1 2.1 2.1 2.1 2.1 2.1 Commercial and other 7.3 7.9 8.2 8.5 8.1
8.4 Commercial paid at episodic rates 9.7 9.6 9.7 9.4 9.5 9.7
Episodic revenues ($ 000s) $ 308,317 $ 324,027 $ 319,820 $ 320,698
$ 1,272,862 $ 325,821 5.7 Total episodic admissions 69,936 67,808
66,753 66,157 270,654 71,426 2.1 Medicare episodic admissions
61,186 59,394 58,479 57,804 236,863 62,011 1.3 Total episodes
110,980 109,599 108,519 108,300 437,398 113,887 2.6 Episodes per
admission 1.59 1.62 1.63 1.64 1.62 1.59 - Revenue per episode $
2,778 $ 2,956 $ 2,947 $ 2,961 $ 2,910 $ 2,861 3.0 Hospice: Sites of
service (at end of period) 190 185 181 175 177 Admissions 13,164
12,574 12,091 12,129 49,958 13,234 0.5 Average length of stay 95 93
101 100 97 92 (3.2 ) Patient days 1,150,841 1,190,604 1,211,291
1,185,330 4,738,066 1,183,908 2.9 Revenue per patient day $ 151 $
150 $ 150 $ 150 $ 150 $ 149 (1.3 ) Average daily census 12,787
13,084 13,166 12,884 12,981 13,010 1.7
Community Care and other revenues
(included in Home Health business segment)
$ 65,530 $ 67,647 $ 67,338 $ 67,684 $ 268,199 $ 66,305 1.2
Kindred Rehabilitation Services: Kindred Hospital
Rehabilitation Services: Freestanding IRFs: End of period data:
Number of IRFs 16 16 18 18 19 Number of licensed beds 829 829 919
919 969 Discharges (a) 3,806 3,927 3,941 4,317 15,991 4,448 16.9
Same-hospital discharges (a) 3,806 3,927 3,842 4,040 15,615 4,016
5.5 Occupancy % (a) 73.2 71.5 68.7 68.0 70.2 70.6 (3.6 ) Average
length of stay (a) 13.7 13.1 13.2 12.7 13.2 13.2 (3.6 ) Revenue per
discharge (a) $ 19,517 $ 19,325 $ 18,992 $ 18,640 $ 19,104 $ 19,731
1.1 Contract services: Sites of service (at end of period):
Inpatient rehabilitation units 100 99 101 100 104 LTAC hospitals
120 120 119 119 119 Sub-acute units 8 8 7 7 7 Outpatient units
138 139 135 130 139 366
366 362 356 369 Revenue per site
$ 211,151 $ 209,436 $ 206,041 $ 210,978 $ 837,606 $ 211,417 0.1
RehabCare: Sites of service (at end of period) 1,829 1,789
1,821 1,798 1,767 Revenue per site $ 138,106 $ 132,359 $ 120,548 $
114,896 $ 505,909 $ 115,590 (16.3 )
Nursing center
division: End of period data: Number of nursing centers 90 90
90 90 92 Number of licensed beds 11,535 11,535 11,535 11,535 11,815
Admissions (b) 10,376 9,831 9,558 9,237 39,002 9,815 (5.4 )
Medicare average length of stay (b) 28.9 28.9 28.5 28.4 28.7 28.2
(2.4 ) Patient days (b) 861,278 852,691 851,332 845,924 3,411,225
846,578 (1.7 ) Revenues per patient day (b) $ 319 $ 321 $ 318 $ 323
$ 320 $ 322 0.9 Average daily census (b) 9,570 9,370 9,254 9,195
9,346 9,303 (2.8 ) Occupancy % (b) 81.3 79.6 78.6 78.1 79.4 77.3
(4.9 )
(a) Excludes non-consolidating IRF.
(b) Excludes managed facilities.
Forward-Looking Statements
This press release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of
1934, as amended. These forward-looking statements include, but are
not limited to, all statements regarding the Company’s expected
future financial position, results of operations, cash flows,
dividends, financing plans, business strategy, budgets, capital
expenditures, competitive positions, growth opportunities, plans
and objectives of management, government investigations, regulatory
matters, and statements containing the words such as “anticipate,”
“approximate,” “believe,” “plan,” “estimate,” “expect,” “project,”
“could,” “would,” “should,” “will,” “intend,” “may,” “potential,”
“upside,” and other similar expressions. Statements in this press
release concerning the Company’s business outlook or future
economic performance, anticipated profitability, revenues,
expenses, dividends or other financial items, product or services
line growth, and expected outcome of government investigations and
other regulatory matters, together with other statements that are
not historical facts, are forward-looking statements that are
estimates reflecting the best judgment of the Company based upon
currently available information.
Such forward-looking statements are inherently uncertain, and
stockholders and other potential investors must recognize that
actual results may differ materially from the Company’s
expectations as a result of a variety of factors. Such
forward-looking statements are based upon management’s current
expectations and include known and unknown risks, uncertainties and
other factors, many of which the Company is unable to predict or
control, that may cause the Company’s actual results, performance
or plans to differ materially from any future results, performance
or plans expressed or implied by such forward-looking statements.
These statements involve risks, uncertainties and other factors
detailed from time to time in the Company’s Annual Report on Form
10-K, Quarterly Reports on Form 10-Q and Current Reports on Form
8-K with the Securities and Exchange Commission.
Many of these factors are beyond the Company’s control. The
Company cautions investors that any forward-looking statements made
by the Company are not guarantees of future performance. The
Company disclaims any obligation to update any such factors or to
announce publicly the results of any revisions to any of the
forward-looking statements to reflect future events or
developments.
Non-GAAP Measurements
In addition to the results provided in accordance with GAAP, the
Company has provided information in this release to compute certain
non-GAAP measurements for the three months ended March 31, 2016 and
2015 before certain charges or on a core and adjusted core basis,
and on a same-hospital basis. The use of these non-GAAP measures
are not intended to replace the presentation of the Company’s
financial results in accordance with GAAP. The Company believes
that the presentation of core operating results provides additional
information to investors to facilitate the comparison between
periods by excluding certain charges that are not representative of
its ongoing operations due to the materiality and nature of the
charges. The Company believes the presentation of adjusted core
operating results, which excludes non-cash expenses related to
amortization of intangible assets, stock-based compensation and
deferred financing costs from core operating results, is a useful
performance measure used by some investors, equity analysts and
others to make informed investment decisions and for comparability
to other companies that use similar measures. The Company believes
the presentation of same-hospital revenues, which excludes the
results from two hospitals that closed during 2015, provides
investors, equity analysts and others with useful information
regarding the performance of the Company's hospital operations that
are comparable for the periods presented. The Company believes that
reported hospital segment revenues is the most comparable GAAP
measure. Readers of the Company’s financial information should
consider reported hospital segment revenues as an important measure
of the Company’s Hospital Division financial performance because it
provides the most complete measure of its revenues. The Company’s
earnings release also includes financial measures referred to as
operating income, or EBITDAR or core EBITDAR, and core earnings
before interest, income taxes, depreciation and amortization (“core
EBITDA”). The Company’s management uses core EBITDAR or core EBITDA
as meaningful measures of operational performance in addition to
other measures. The Company uses core EBITDAR or core EBITDA to
assess the relative performance of its operating divisions as well
as the employees that operate these businesses. In addition, the
Company believes these measurements are important because
securities analysts and investors use these measurements to compare
the Company’s performance to other companies in the healthcare
industry. The Company believes that income (loss) from continuing
operations is the most comparable GAAP measure. Readers of the
Company’s financial information should consider income (loss) from
continuing operations as an important measure of the Company’s
financial performance because it provides the most complete measure
of its performance. Operating results presented on a core and
adjusted core basis and core EBITDAR or core EBITDA, as well as a
same-hospital basis, should be considered in addition to, not as a
substitute for, or superior to, financial measures based upon GAAP
as an indicator of operating performance. Reconciliations of the
non-GAAP measurements to the GAAP measurements are included in the
following pages of this press release.
Also in this press release, the Company provides the financial
measures of operating cash flows and free cash flows excluding
certain items, which the Company refers to as core operating cash
flows and core free cash flows. The Company recognizes that core
operating cash flows and core free cash flows are non-GAAP
measurements and are not intended to replace the presentation of
the Company’s cash flows in accordance with GAAP. The Company
believes that these non-GAAP measurements provide important
information to investors for comparability to other companies that
use similar measures. In addition, management uses core operating
cash flows and core free cash flows in making decisions related to
acquisitions, development capital expenditures, dividends,
long-term debt repayments and other uses. The Company believes net
cash flows provided by operating activities is the most comparable
GAAP measure. Readers of the Company’s financial information should
consider net cash flows provided by operating activities as an
important measure of the Company’s financial performance because it
provides the most complete measure of its performance. Core
operating cash flows and core free cash flows should be considered
in addition to, not as a substitute for, or superior to, financial
measures based upon GAAP as an indicator of operating performance.
Reconciliations of net cash flows provided by operating activities
to core operating cash flows and core free cash flows are included
in this press release.
KINDRED HEALTHCARE, INC. Reconciliation of
Non-GAAP Measurements to GAAP Results (Unaudited) (In
thousands, except per share amounts and statistics)
In addition to the
results provided in accordance with GAAP, the Company has provided
information in this release to compute certain non-GAAP
measurements for the three months ended March 31, 2016 and 2015
before certain charges or on a core basis. The charges that were
excluded from core operating results are denoted in the tables
below. The income tax benefit associated with the excluded
charges was calculated using an effective income tax rate of 34.3%
and 22.6% for the three months ended March 31, 2016 and 2015,
respectively. The difference in the effective income tax rate for
both periods compared to the same prior year periods is
attributable to the composition of charges that are non-deductible
for income tax purposes, including the litigation contingency
expense.
Three months ended March 31,
Detail of charges:
2016 2015 Litigation contingency
expense ($1,910 ) ($95,000 ) Retirement and severance costs (1,582
) (4,961 ) Home health and hospice closings (341 ) (1,619 )
Property and equipment impairment charges (7,788 ) - Business
interruption settlements 1,138 - Research and development (863 ) -
Development project cancellation and other restructuring costs -
(1,027 ) Gentiva transaction and integration costs: Professional
and consulting fees (1,048 ) (32,134 ) Severance and retention (555
) (54,464 ) Lease termination (charged to rent expense) - (589 )
Pre-closing financing charges (charged to general and
administrative expenses) - (6,005 ) Pre-closing financing charges
(charged to interest expense) - (17,431 ) Trade name impairment
charges - (6,726 ) Lease termination (charged to rent expense) (251
) - Other transaction costs (518 ) (2,099 ) (13,718 )
(222,055 ) Income tax benefit 4,710 50,202
Charges net of income taxes (9,008 ) (171,853 ) Allocation
to participating unvested restricted stockholders 133
- Available to common stockholders ($8,875 )
($171,853 ) Weighted average diluted shares outstanding
87,249 79,575 Diluted earnings (loss)
per common share related to charges ($0.10 ) ($2.16 )
Reconciliation of income from continuing operations before
charges: Amounts attributable to Kindred stockholders: Income from
continuing operations before charges $ 22,331 $ 28,418 Charges net
of income taxes (9,008 ) (171,853 ) Reported income
(loss) from continuing operations $ 13,323 ($143,435
) Reconciliation of core diluted EPS from continuing
operations: Diluted core EPS (a) $ 0.25 $ 0.34 Charges net of
income taxes (0.10 ) (2.16 ) Other - 0.02
Reported diluted earnings (loss) per common share from
continuing operations $ 0.15 ($1.80 )
Weighted average diluted shares used to
compute earnings per common share from continuing operations before
charges
87,249 82,422 Reconciliation of
effective income tax rate before charges: Effective income tax rate
before charges 32.2 % 37.6 % Impact of charges on effective income
tax rate -0.8 % -20.5 % Reported effective income tax
rate 31.4 % 17.1 %
__________
(a) For purposes of computing diluted
earnings per common share before charges, income from continuing
operations before charges was reduced by $0.3 million and $0.5
million for the three months ended March 31, 2016 and 2015,
respectively, for the allocation of income to participating
unvested restricted stockholders.
KINDRED HEALTHCARE, INC.
Reconciliation of Non-GAAP Measurements to GAAP Results
(Continued) (Unaudited) (In thousands, except per share
amounts and statistics) A reconciliation of adjusted
core earnings follows:
First 2015 Quarters
Quarter Reconciliation of adjusted core earnings:
First Second Third Fourth Year
2016
Income from continuing operations before
charges (as calculated and reconciled to GAAP measurement on the
following pages)
$ 28,418 $ 34,051 $ 20,506 $ 29,039 $ 112,014 $ 22,331 Add back
non-cash expenses: Amortization of intangible assets 6,932 7,536
7,728 7,645 29,841 6,826 Amortization of stock-based compensation
costs 3,141 6,687 3,194 4,778 17,800 3,746 Amortization of deferred
financing costs 3,062 3,539 3,554
3,566 13,721 3,567 13,135 17,762 14,476
15,989 61,362 14,139 Income tax benefit related to non-cash
expenses 5,169 6,989 5,696 6,292
24,146 5,564 Non-cash expenses, net of income
taxes 7,966 10,773 8,780 9,697
37,216 8,575 Adjusted core earnings $ 36,384 $
44,824 $ 29,286 $ 38,736 $ 149,230 $ 30,906
Reconciliation of diluted adjusted core earnings from continuing
operations:
Diluted income per common share before
charges (as calculated on the following pages)
$ 0.34 $ 0.39 $ 0.23 $ 0.33 $ 1.28 $ 0.25 Non-cash expenses, net of
income taxes 0.09 0.12 0.10 0.11
0.42 0.10 Adjusted diluted core EPS from
continuing operations $ 0.43 $ 0.51 $ 0.33 $ 0.44 $ 1.70
$ 0.35
Weighted average diluted shares used to
compute adjusted core EPS
82,422 86,402 86,892 87,232
86,098 87,249 A
reconciliation of combined Kindred and Gentiva home health revenues
(excluding community care) for each historical period follows:
First First quarter 2015 Quarters
Quarter % change v. First Second
Third Fourth Year 2016 prior
year Kindred $ 254,965 $ 360,173 $ 356,716 $ 358,075 $
1,329,929 $ 363,730 Gentiva 87,520 - -
- 87,520 - $ 342,485 $ 360,173 $
356,716 $ 358,075 $ 1,417,449 $ 363,730 6.2
A reconciliation of same-hospital revenues to
reported revenues for the Hospital Division for each historical
period follows:
First First quarter 2015
Quarters Quarter % change v. First
Second Third Fourth Year 2016
prior year Same-hospital revenues $ 634,975 $ 622,018 $
577,337 $ 594,091 $ 2,428,421 $ 643,413 1.3 Two hospitals that
closed during 2015 (a) 5,508 5,188 2,160
(498 ) 12,358 (114 ) Reported revenues $
640,483 $ 627,206 $ 579,497 $ 593,593 $ 2,440,779 $ 643,299
0.4
__________
(a) One hospital closed during the second
quarter of 2015 and one hospital closed during the third quarter of
2015.
KINDRED HEALTHCARE, INC. Reconciliation of
Non-GAAP Measurements to GAAP Results (Continued)
(Unaudited) (In thousands, except per share amounts)
Three months
ended March 31, 2016 Charges Gentiva
Before Retirement Business transaction
charges and Hospice interruption
Litigation Impairment Research and and
Other As ("core") severance
closings settlements contingency
charges development integration
transaction Total reported Income from
continuing operations: Operating income (loss) (EBITDAR):
Hospital division $ 135,495 $ (924 ) $ - $ - $ - $ - $ - $ - $ - $
(924 ) $ 134,571 Kindred at Home: Home health 65,803 - -
1,138 - - - - - 1,138 66,941 Hospice 24,866 -
(341 ) - - -
- - - (341
) 24,525 90,669 -
(341 ) 1,138 - - -
- - 797
91,466 Kindred Rehabilitation Services: Kindred
Hospital Rehabilitation Services 47,870 - - - - - - - - - 47,870
RehabCare 11,987 - -
- - - -
- - - 11,987
59,857 - -
- - - - -
- - 59,857
Nursing center division 30,100 - - - - - - - - - 30,100
Support center (69,287 ) (658 ) - - - - (863 ) - - (1,521 ) (70,808
) Litigation contingency expense - - - - (1,910 ) - - - - (1,910 )
(1,910 ) Impairment charges - - - - - (7,788 ) - - - (7,788 )
(7,788 ) Transaction costs - - -
- - - -
(1,603 ) (518 ) (2,121 ) (2,121
) Operating income (EBITDAR) 246,834 (1,582 ) (341 ) 1,138 (1,910 )
(7,788 ) (863 ) (1,603 ) (518 ) (13,467 ) 233,367 Rent
(97,517 ) - (251 ) - -
- - - -
(251 ) (97,768 ) EBITDA 149,317 (1,582 ) (592
) 1,138 (1,910 ) (7,788 ) (863 ) (1,603 ) (518 ) (13,718 ) 135,599
Depreciation and amortization (40,681 ) - - - - - - - - - (40,681 )
Interest, net (57,245 ) - -
- - - -
- - - (57,245 )
Income from continuing operations before
income taxes
51,391 (1,582 ) (592 ) 1,138 (1,910 ) (7,788 ) (863 ) (1,603 ) (518
) (13,718 ) 37,673 Provision for income taxes 16,546
(543 ) (203 ) 391 (656 )
(2,674 ) (296 ) (551 ) (178 ) (4,710 )
11,836 34,845 $ (1,039 ) $ (389 ) $ 747 $
(1,254 ) $ (5,114 ) $ (567 ) $ (1,052 ) $ (340 ) $ (9,008 ) 25,837
Noncontrolling interests (12,514 ) (12,514 ) Income
(loss) attributable to Kindred $ 22,331 $ 13,323
Diluted earnings (loss) per common share $ 0.25 $ 0.15
Diluted shares used in computing earnings
per common share
87,249 87,249
Three months ended March 31, 2015
Charges Home health Development Gentiva
Gentiva Before Retirement and
project pre-closing transaction charges
and hospice cancellation Litigation
Impairment financing and Other
As ("core") severance closings and
other contingency charges costs
integration transaction Total reported
Income (loss) from continuing operations: Operating income
(loss) (EBITDAR): Hospital division $ 134,786 $ - $ - $ (675 ) $ -
$ - $ - $ - $ - $ (675 ) $ 134,111 Kindred at Home: Home
health 46,798 - (1,102 ) - - - - - - (1,102 ) 45,696 Hospice
16,996 - (517 ) -
- - - - -
(517 ) 16,479 63,794
- (1,619 ) - -
- - - -
(1,619 ) 62,175 Kindred Rehabilitation
Services: Kindred Hospital Rehabilitation Services 44,564 - - - - -
- - - - 44,564 RehabCare 16,493 (785 )
- - - - -
- - (785 ) 15,708
61,057 (785 ) - -
- - - -
- (785 ) 60,272
Nursing center division 36,963 - - - - - - - - - 36,963
Support center (62,389 ) (4,176 ) - - - - - - - (4,176 ) (66,565 )
Litigation contingency expense - - - - (95,000 ) - - - - (95,000 )
(95,000 ) Impairment charges - - - - - (6,726 ) - - - (6,726 )
(6,726 ) Transaction costs - - -
- - -
(6,005 ) (86,598 ) (2,099 ) (94,702 )
(94,702 ) Operating income (EBITDAR) 234,211 (4,961 ) (1,619 ) (675
) (95,000 ) (6,726 ) (6,005 ) (86,598 ) (2,099 ) (203,683 ) 30,528
Rent (91,199 ) - - (352 )
- - - (589 )
- (941 ) (92,140 ) EBITDA 143,012
(4,961 ) (1,619 ) (1,027 ) (95,000 ) (6,726 ) (6,005 ) (87,187 )
(2,099 ) (204,624 ) (61,612 ) Depreciation and amortization (38,935
) - - - - - - - - - (38,935 ) Interest, net (44,346 )
- - - - -
(17,431 ) - -
(17,431 ) (61,777 )
Income (loss) from continuing operations
before income taxes
59,731 (4,961 ) (1,619 ) (1,027 ) (95,000 ) (6,726 ) (23,436 )
(87,187 ) (2,099 ) (222,055 ) (162,324 ) Provision (benefit) for
income taxes 22,466 (2,133 ) (696 )
(442 ) - (2,891 ) (10,075 )
(33,063 ) (902 ) (50,202 ) (27,736 )
37,265 $ (2,828 ) $ (923 ) $ (585 ) $ (95,000 ) $ (3,835 ) $
(13,361 ) $ (54,124 ) $ (1,197 ) $ (171,853 ) (134,588 )
Noncontrolling interests (8,847 ) (8,847 ) Income
(loss) attributable to Kindred $ 28,418 $ (143,435 )
Diluted earnings (loss) per common share $ 0.34 $ (1.80 )
Diluted shares used in computing earnings
(loss) per common share
82,422 79,575
KINDRED HEALTHCARE, INC.
Reconciliation of Non-GAAP Measurements to GAAP Results
(Continued) (Unaudited) (In thousands, except per share
amounts)
Three months ended
June 30, 2015 Charges Hospital Development
Gentiva Before and home project
transaction charges health/hospice
cancellation Litigation and Other
As ("core") closings and other
contingency integration transaction
Total reported Income from continuing
operations: Operating income (loss) (EBITDAR): Hospital
division $ 131,532 $ (565 ) $ - $ - $ - $ - $ (565 ) $ 130,967
Kindred at Home: Home health 72,917 (588 ) - - - - (588 )
72,329 Hospice 27,887 (1,649 ) -
- - - (1,649 )
26,238 100,804 (2,237 ) -
- - -
(2,237 ) 98,567 Kindred Rehabilitation
Services: Kindred Hospital Rehabilitation Services 44,531 - - - - -
- 44,531 RehabCare 14,681 - -
- - - -
14,681 59,212 -
- - - -
- 59,212 Nursing center division
40,461 - (584 ) - - - (584 ) 39,877 Support center (70,209 )
- - - - - - (70,209 ) Litigation contingency expense - - - (3,925 )
- - (3,925 ) (3,925 ) Transaction costs - -
- - (4,342 ) (874
) (5,216 ) (5,216 ) Operating income (EBITDAR)
261,800 (2,802 ) (584 ) (3,925 ) (4,342 ) (874 ) (12,527 ) 249,273
Rent (95,528 ) (671 ) - -
(203 ) - (874 ) (96,402 ) EBITDA
166,272 (3,473 ) (584 ) (3,925 ) (4,545 ) (874 ) (13,401 ) 152,871
Depreciation and amortization (38,625 ) - - - - - - (38,625 )
Interest, net (56,140 ) - -
- - - -
(56,140 )
Income from continuing operations before
income taxes
71,507 (3,473 ) (584 ) (3,925 ) (4,545 ) (874 ) (13,401 ) 58,106
Provision for income taxes 25,721 (368 )
(62 ) (416 ) (386 ) (93 ) (1,325
) 24,396 45,786 $ (3,105 ) $ (522 ) $ (3,509 ) $
(4,159 ) $ (781 ) $ (12,076 ) 33,710 Noncontrolling interests
(11,735 ) (11,735 ) Income attributable to Kindred $
34,051 $ 21,975 Diluted earnings per common
share $ 0.39 $ 0.25
Diluted shares used in computing earnings
per common share
86,402 86,402
Three months ended September 30, 2015
Charges Hospital Gentiva Before
Retirement and home transaction charges
and health/hospice Litigation and
Other As ("core") severance
closings contingency integration
transaction Total reported Income (loss)
from continuing operations: Operating income (loss) (EBITDAR):
Hospital division $ 97,128 $ (666 ) $ (479 ) $ - $ - $ - $ (1,145 )
$ 95,983 Kindred at Home: Home health 68,155 - (2,571 ) - -
- (2,571 ) 65,584 Hospice 34,025 -
(318 ) - - -
(318 ) 33,707 102,180 -
(2,889 ) - - -
(2,889 ) 99,291 Kindred
Rehabilitation Services: Kindred Hospital Rehabilitation Services
42,141 - - - - - - 42,141 RehabCare 14,544 -
- - - -
- 14,544 56,685
- - - -
- - 56,685 Nursing
center division 35,923 - - - - - - 35,923 Support center
(55,439 ) - - - - - - (55,439 ) Litigation contingency expense - -
- (31,462 ) - - (31,462 ) (31,462 ) Transaction costs -
- - -
(3,069 ) (777 ) (3,846 ) (3,846 ) Operating
income (EBITDAR) 236,477 (666 ) (3,368 ) (31,462 ) (3,069 ) (777 )
(39,342 ) 197,135 Rent (95,436 ) - (808
) - - - (808 )
(96,244 ) EBITDA 141,041 (666 ) (4,176 ) (31,462 ) (3,069 )
(777 ) (40,150 ) 100,891 Depreciation and amortization (39,329 ) -
- - - - - (39,329 ) Interest, net (56,008 ) -
- - - -
- (56,008 )
Income from continuing operations before
income taxes
45,704 (666 ) (4,176 ) (31,462 ) (3,069 ) (777 ) (40,150 ) 5,554
Provision for income taxes 15,298 (196 )
(1,225 ) (429 ) (697 ) (228 )
(2,775 ) 12,523 30,406 $ (470 ) $ (2,951 ) $ (31,033
) $ (2,372 ) $ (549 ) $ (37,375 ) (6,969 ) Noncontrolling interests
(9,900 ) (9,900 ) Income (loss) attributable to
Kindred $ 20,506 $ (16,869 ) Diluted earnings (loss)
per common share $ 0.23 $ (0.20 )
Diluted shares used in computing earnings
(loss) per common share
86,892 86,184
KINDRED HEALTHCARE, INC.
Reconciliation of Non-GAAP Measurements to GAAP Results
(Continued) (Unaudited) (In thousands, except per share
amounts)
Three months ended December 31, 2015 Charges
Hospital RehabCare Gentiva Before
Retirement and home customer
transaction charges and health/hospice
contract Litigation Impairment and
Other As ("core") severance
closings litigation contingency charges
integration transaction Total reported
Income from continuing operations: Operating income (loss)
(EBITDAR): Hospital division $ 117,675 $ (1,221 ) $ - $ - $ - $ - $
- $ - $ (1,221 ) $ 116,454 Kindred at Home: Home health
68,826 - (1,794 ) - - - - - (1,794 ) 67,032 Hospice 30,212
- (1,544 ) - -
- - -
(1,544 ) 28,668 99,038 -
(3,338 ) - - -
- - (3,338 ) 95,700
Kindred Rehabilitation Services: Kindred Hospital
Rehabilitation Services 45,098 (207 ) - - - - - - (207 ) 44,891
RehabCare 11,858 (112 ) -
(12,864 ) - - - -
(12,976 ) (1,118 ) 56,956
(319 ) - (12,864 ) - -
- - (13,183 )
43,773 Nursing center division 36,601 - - - - - - - -
36,601 Support center (62,431 ) (585 ) - - - - - - (585 )
(63,016 ) Litigation contingency expense - - - - (8,261 ) - -
(8,261 ) (8,261 ) Impairment charges - - - - - (18,031 ) - -
(18,031 ) (18,031 ) Transaction costs - -
- - - -
(4,189 ) (1,178 ) (5,367 )
(5,367 ) Operating income (EBITDAR) 247,839 (2,125 ) (3,338 )
(12,864 ) (8,261 ) (18,031 ) (4,189 ) (1,178 ) (49,986 ) 197,853
Rent (96,934 ) - (889 ) -
- - - -
(889 ) (97,823 ) EBITDA 150,905 (2,125 ) (4,227 )
(12,864 ) (8,261 ) (18,031 ) (4,189 ) (1,178 ) (50,875 ) 100,030
Depreciation and amortization (40,362 ) - - - - - - - - (40,362 )
Interest, net (55,664 ) - -
- - - -
- - (55,664 )
Income from continuing operations before
income taxes
54,879 (2,125 ) (4,227 ) (12,864 ) (8,261 ) (18,031 ) (4,189 )
(1,178 ) (50,875 ) 4,004 Provision (benefit) for income taxes
13,758 (836 ) (1,663 ) (5,062 )
(50,329 ) (6,205 ) (1,487 ) (156 )
(65,738 ) (51,980 ) 41,121 $ (1,289 ) $ (2,564 ) $
(7,802 ) $ 42,068 $ (11,826 ) $ (2,702 ) $ (1,022 ) $ 14,863
55,984 Noncontrolling interests (12,082 )
(12,082 ) Income attributable to Kindred $ 29,039 $ 43,902
Diluted earnings per common share $ 0.33 $ 0.50
Diluted shares used in computing earnings
per common share
87,232 87,232
Year ended December 31, 2015
Charges Hospital Development RehabCare
Gentiva Gentiva Before Retirement
and home project customer pre-closing
transaction charges and health/hospice
cancellation contract Litigation
Impairment financing and Other
As ("core") severance closings and
other litigation contingency charges
costs integration transaction Total
reported Income (loss) from continuing operations:
Operating income (loss) (EBITDAR): Hospital division $ 481,121 $
(1,887 ) $ (1,044 ) $ (675 ) $ - $ - $ - $ - $ - $ - $ (3,606 ) $
477,515 Kindred at Home: Home health 256,696 - (6,055 ) - -
- - - - - (6,055 ) 250,641 Hospice 109,120 -
(4,028 ) - - -
- - - -
(4,028 ) 105,092 365,816
- (10,083 ) - -
- - - -
- (10,083 ) 355,733
Kindred Rehabilitation Services: Kindred Hospital Rehabilitation
Services 176,334 (207 ) - - - - - - - - (207 ) 176,127 RehabCare
57,576 (897 ) - -
(12,864 ) - - -
- - (13,761 ) 43,815
233,910 (1,104 ) -
- (12,864 ) - - -
- - (13,968 )
219,942 Nursing center division 149,948 - - (584 ) -
- - - - - (584 ) 149,364 Support center (250,468 ) (4,761 )
- - - - - - - - (4,761 ) (255,229 ) Litigation contingency expense
- - - - - (138,648 ) - - - - (138,648 ) (138,648 ) Impairment
charges - - - - - - (24,757 ) - - - (24,757 ) (24,757 ) Transaction
costs - - - -
- - -
(6,005 ) (98,198 ) (4,928 ) (109,131 )
(109,131 ) Operating income (EBITDAR) 980,327 (7,752 ) (11,127 )
(1,259 ) (12,864 ) (138,648 ) (24,757 ) (6,005 ) (98,198 ) (4,928 )
(305,538 ) 674,789 Rent (379,097 ) -
(2,368 ) (352 ) - - -
- (792 ) - (3,512
) (382,609 ) EBITDA 601,230 (7,752 ) (13,495 ) (1,611 )
(12,864 ) (138,648 ) (24,757 ) (6,005 ) (98,990 ) (4,928 ) (309,050
) 292,180 Depreciation and amortization (157,251 ) - - - - - - - -
- - (157,251 ) Interest, net (212,158 ) -
- - - -
- (17,431 ) - -
(17,431 ) (229,589 )
Income (loss) from continuing operations
before income taxes
231,821 (7,752 ) (13,495 ) (1,611 ) (12,864 ) (138,648 ) (24,757 )
(23,436 ) (98,990 ) (4,928 ) (326,481 ) (94,660 ) Provision for
income taxes 77,243 (3,063 ) (5,333 )
(637 ) (5,084 ) (51,965 ) (8,890 )
(9,261 ) (34,266 ) (1,541 ) (120,040 )
(42,797 ) 154,578 $ (4,689 ) $ (8,162 ) $ (974 ) $ (7,780 )
$ (86,683 ) $ (15,867 ) $ (14,175 ) $ (64,724 ) $ (3,387 ) $
(206,441 ) (51,863 ) Noncontrolling interests (42,564 )
(42,564 ) Income (loss) attributable to Kindred $ 112,014
$ (94,427 ) Diluted earnings (loss) per common share
$ 1.28 $ (1.12 )
Diluted shares used in computing earnings
(loss) per common share
86,098 84,558
KINDRED HEALTHCARE, INC.
Reconciliation of Non-GAAP Measurements to GAAP Results
(Continued) (Unaudited) (In thousands)
Three months ended
March 31, 2016 2015 Reconciliation of
net cash flows provided by operating activities to free cash flows:
Net cash flows used in operating activities
($133,062
) ($139,602 )
Adjustments to remove certain payments
(including payments made for discontinued operations) included in
net cash flows used in operating activities:
Transaction, severance, retirement and retention
5,379
82,340 Business interruption settlements
(1,138 ) -
Ventas, Inc. lease termination fee
- 40,000 Capitalized
lender fees related to debt refinancing
- 28,012 Other debt
refinancing costs (expensed)
- 27,001 Other lease
termination fees
- 353 Litigation
128,419
-
132,660 177,706
Net cash flows provided by (used in)
operating activities excluding certain items before income tax
benefit of certain payments
(402 ) 38,104 Benefit of reduced income tax payments
resulting from certain payments (a)
- -
Net cash flows provided by (used in)
operating activities excluding certain items (core operating cash
flows)
(402 ) 38,104 Less routine capital
expenditures
(18,106 ) (20,769 ) Less distributions
to noncontrolling interests
(16,315 ) (11,019
) Free cash flows excluding certain items (core free cash flows)
($34,823 ) $ 6,316
__________
(a) No tax deposits were due in first quarter of 2016 or 2015.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160504006621/en/
Kindred Healthcare, Inc.Todd Flowers, 502-596-6569Investor
Relations
Kindred Healthcare (NYSE:KND)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kindred Healthcare (NYSE:KND)
Historical Stock Chart
From Apr 2023 to Apr 2024